Neuralink Reports 2,000 Days of Brain Chip Use By 12 Patients Under Elon Musk’s Company

This article does not constitute investment advice. The author does not hold any positions in the stocks mentioned herein.

Neuralink Announces 12 Patients Are Now Using Its Brain Implants

In a significant announcement, Neuralink, the innovative medical implant company founded by Elon Musk, has revealed that there are currently 12 patients using its brain-computer interface (BCI) products across the globe. These individuals have collectively utilized the devices for an impressive total of 15, 335 hours over the span of 2, 000 days, marking a critical milestone for the company as it ventures into the realm of neurological therapies.

First Patient’s Remarkable Experience

Neuralink has been garnering attention recently thanks to its first patient, Noland Arbaugh, who shared his inspiring journey in a recent interview with Fortune Magazine. Arbaugh, who was paralyzed from the waist down after a swimming accident in 2016, expressed how the Neuralink implant transformed his life, stating he felt as though he was “playing catch-up for eight years of not doing anything.”Since receiving the implant in 2014, he has been able to engage in activities like video gaming and language learning.

As one of the initial 12 patients with access to Neuralink’s brain implants, Arbaugh stands as a testament to the potential of this groundbreaking technology. In a social media update, Neuralink affirmed that these 12 patients are pioneering the use of their devices, which have continuously been refined and improved upon over the years.

There are now 12 people around the world with Neuralink implants. Collectively, they’ve had their devices for 2, 000 days and accumulated over 15, 000 hours of use. We look forward to continuing to explore the possibilities of neural interfaces with all of our participants! pic.twitter.com/OCuDN40abx

— Neuralink (@neuralink) September 9, 2025

Recent Surgeries and Clinical Trials Ahead

The recent update from Neuralink follows the company’s first surgical operations outside the United States, conducted earlier this month. On August 27 and September 8, Neuralink performed vital surgeries as part of a groundbreaking four-year clinical trial in collaboration with the University Health Network (UHN) in Canada. This trial is primarily focused on assessing whether quadriplegic individuals can control devices using only their thoughts.

Neuralink’s Canadian initiatives are merely one facet of its global clinical trials. In July, the company announced it had received regulatory approvals from the UK for its GB-PRIME clinical study, which seeks to further investigate how paralyzed patients can navigate the digital world through thought alone.

Musk’s Ambitious Vision for Neuralink

True to his form, Elon Musk has set ambitious goals for Neuralink. During a 2020 presentation, he outlined his vision of eventually reducing the costs associated with brain chip implantation to just a few thousand dollars. Since receiving FDA approval in 2023 to commence human trials, Neuralink has made substantial progress towards that goal, igniting interest and anticipation in the field of neurotechnology.

Source & Images